States get option to cover uninsured people with serious mental illness

What it does

This bill creates a new optional Medicaid pathway for states to cover uninsured individuals earning up to 100% of the federal poverty line who have been diagnosed with serious mental illness, serious emotional disturbance, opioid use disorder, or stimulant use disorder. States choosing to participate must ensure enrollees receive a care plan within 60 days and report quality metrics; coverage lasts one year initially with optional annual renewals.

Why we flagged it

The bill's core mechanism is a voluntary state option to extend Medicaid coverage to a specific, clinically defined population (uninsured individuals with serious mental illness or substance use disorders). It is a public health measure, not a tax provision, deregulation, or private carve-out.

What the text implies

• States retain discretion to opt in or out, creating potential coverage gaps and interstate disparities in access to behavioral health services for the poorest uninsured individuals.
• The 100% poverty-line income cap is restrictive; many individuals with serious mental illness or substance use disorder earn slightly above this threshold and would remain uninsured.
• Reliance on state redetermination of eligibility at each annual renewal may create administrative churn and coverage lapses for individuals with chronic conditions.
• Pharmaceutical and behavioral health service providers (named in mapped stocks) may see increased demand for medications and services, but the bill does not establish pricing controls or preferred-provider arrangements, leaving reimbursement rates to state negotiation.

Section numbers refer to the bill text the analysis read — linked under Primary records below.

Who it affects

The bill expands health coverage to a vulnerable, underserved population (uninsured individuals with serious behavioral health conditions) at no cost to them, with mandatory care coordination and quality reporting. The primary cost falls on states (through Medicaid) and the federal government, not on citizens; the mechanism is transparent and protective.

Who stands to gain

• pharmaceutical manufacturers (antipsychotics, opioid-use-disorder medications, stimulant-use-disorde
• behavioral health service providers and clinics
• community mental health centers and certified community behavioral health clinics
• healthcare providers and hospitals (emergency departments, primary care)

Named in the bill

Centers for Medicare & Medicaid Services (CMS), State Medicaid agencies, Certified Community Behavioral Health Clinics, Institutions for Mental Diseases, Bristol Myers Squibb (BMY), Gilead Sciences (GH), Pfizer (PFE), DaVita (DVA), Johnson & Johnson (JNJ), Social Security Act Section 1902, Protecting Access to Medicare Act of 2014

Where it stands

• Dec 3, 2025 — Introduced · Congress.gov: “Introduced in House”
• Dec 3, 2025 — Referred to House Committee on Energy and Commerce · Congress.gov: “Referred to the House Committee on Energy and Commerce”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.